These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21533062)

  • 1. LARGE expression augments the glycosylation of glycoproteins in addition to α-dystroglycan conferring laminin binding.
    Zhang Z; Zhang P; Hu H
    PLoS One; 2011 Apr; 6(4):e19080. PubMed ID: 21533062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential glycosylation of α-dystroglycan and proteins other than α-dystroglycan by like-glycosyltransferase.
    Zhang P; Hu H
    Glycobiology; 2012 Feb; 22(2):235-47. PubMed ID: 21930648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse large can modify complex N- and mucin O-glycans on alpha-dystroglycan to induce laminin binding.
    Patnaik SK; Stanley P
    J Biol Chem; 2005 May; 280(21):20851-9. PubMed ID: 15788414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies.
    Barresi R; Michele DE; Kanagawa M; Harper HA; Dovico SA; Satz JS; Moore SA; Zhang W; Schachter H; Dumanski JP; Cohn RD; Nishino I; Campbell KP
    Nat Med; 2004 Jul; 10(7):696-703. PubMed ID: 15184894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the LARGE family of putative glycosyltransferases associated with dystroglycanopathies.
    Grewal PK; McLaughlan JM; Moore CJ; Browning CA; Hewitt JE
    Glycobiology; 2005 Oct; 15(10):912-23. PubMed ID: 15958417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous glucuronyltransferase activity of LARGE or LARGE2 required for functional modification of α-dystroglycan in cells and tissues.
    Inamori K; Willer T; Hara Y; Venzke D; Anderson ME; Clarke NF; Guicheney P; Bönnemann CG; Moore SA; Campbell KP
    J Biol Chem; 2014 Oct; 289(41):28138-48. PubMed ID: 25138275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt-driven LARGE2 mediates laminin-adhesive O-glycosylation in human colonic epithelial cells and colorectal cancer.
    Dietinger V; García de Durango CR; Wiechmann S; Boos SL; Michl M; Neumann J; Hermeking H; Kuster B; Jung P
    Cell Commun Signal; 2020 Jun; 18(1):102. PubMed ID: 32586342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous expression of the glycosyltransferase LARGE1 restores α-dystroglycan matriglycan and laminin binding in rhabdomyosarcoma.
    Beltrán D; Anderson ME; Bharathy N; Settelmeyer TP; Svalina MN; Bajwa Z; Shern JF; Gultekin SH; Cuellar MA; Yonekawa T; Keller C; Campbell KP
    Skelet Muscle; 2019 May; 9(1):11. PubMed ID: 31054580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy.
    Kanagawa M; Nishimoto A; Chiyonobu T; Takeda S; Miyagoe-Suzuki Y; Wang F; Fujikake N; Taniguchi M; Lu Z; Tachikawa M; Nagai Y; Tashiro F; Miyazaki J; Tajima Y; Takeda S; Endo T; Kobayashi K; Campbell KP; Toda T
    Hum Mol Genet; 2009 Feb; 18(4):621-31. PubMed ID: 19017726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of deregulated like-acetylglucosaminyl transferase and aberrant α-dystroglycan expression with human tongue cancer metastasis.
    Zhang HZ; Xia XY; Zhu F; Shen H; Song K; Shang ZJ
    J Oral Maxillofac Surg; 2014 Jun; 72(6):1106-18. PubMed ID: 24629698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of perlecan binding and matrix assembly by post-translational or genetic disruption of dystroglycan function.
    Kanagawa M; Michele DE; Satz JS; Barresi R; Kusano H; Sasaki T; Timpl R; Henry MD; Campbell KP
    FEBS Lett; 2005 Aug; 579(21):4792-6. PubMed ID: 16098969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adeno-associated viral-mediated LARGE gene therapy rescues the muscular dystrophic phenotype in mouse models of dystroglycanopathy.
    Yu M; He Y; Wang K; Zhang P; Zhang S; Hu H
    Hum Gene Ther; 2013 Mar; 24(3):317-30. PubMed ID: 23379513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of post-phosphoryl modification in dystroglycanopathy mouse models and wild-type tissues expressing non-laminin binding form of α-dystroglycan.
    Kuga A; Kanagawa M; Sudo A; Chan YM; Tajiri M; Manya H; Kikkawa Y; Nomizu M; Kobayashi K; Endo T; Lu QL; Wada Y; Toda T
    J Biol Chem; 2012 Mar; 287(12):9560-7. PubMed ID: 22270369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcolemma instability during mechanical activity in Largemyd cardiac myocytes with loss of dystroglycan extracellular matrix receptor function.
    Kabaeva Z; Meekhof KE; Michele DE
    Hum Mol Genet; 2011 Sep; 20(17):3346-55. PubMed ID: 21628317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Like-acetylglucosaminyltransferase (LARGE)-dependent modification of dystroglycan at Thr-317/319 is required for laminin binding and arenavirus infection.
    Hara Y; Kanagawa M; Kunz S; Yoshida-Moriguchi T; Satz JS; Kobayashi YM; Zhu Z; Burden SJ; Oldstone MB; Campbell KP
    Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17426-31. PubMed ID: 21987822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding.
    Yoshida-Moriguchi T; Yu L; Stalnaker SH; Davis S; Kunz S; Madson M; Oldstone MB; Schachter H; Wells L; Campbell KP
    Science; 2010 Jan; 327(5961):88-92. PubMed ID: 20044576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An atypical expression of core α-Dystroglycan and Laminin-α2 in skin fibroblasts of patients with congenital muscular dystrophies.
    Sabry S; Issa MY; Abdel-Hamid MS; Eissa NR; Abdel-Ghafar SF; Ibrahim MM; Zaki MS
    Mol Biol Rep; 2023 Aug; 50(8):6373-6379. PubMed ID: 37318662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of dystroglycan, fukutin and POMGnT1 during mouse cerebellar development.
    Henion TR; Qu Q; Smith FI
    Brain Res Mol Brain Res; 2003 Apr; 112(1-2):177-81. PubMed ID: 12670716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pikachurin interaction with dystroglycan is diminished by defective O-mannosyl glycosylation in congenital muscular dystrophy models and rescued by LARGE overexpression.
    Hu H; Li J; Zhang Z; Yu M
    Neurosci Lett; 2011 Feb; 489(1):10-5. PubMed ID: 21129441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal domain on dystroglycan enables LARGE1 to extend matriglycan on α-dystroglycan and prevents muscular dystrophy.
    Okuma H; Hord JM; Chandel I; Venzke D; Anderson ME; Walimbe AS; Joseph S; Gastel Z; Hara Y; Saito F; Matsumura K; Campbell KP
    Elife; 2023 Feb; 12():. PubMed ID: 36723429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.